Methylprednisolone aceponate* in eczema and other inflammatory skin disorders - a clinical update
Author:
- 20 December 2005
- journal article
- review article
- Published by Hindawi Limited in International Journal Of Clinical Practice
- Vol. 60 (1) , 85-92
Abstract
Methylprednisolone aceponate (MPA) has been shown to provide rapid, reliable and highly effective treatment of eczematous disorders, with an efficacy comparable to that of most reference topical corticosteroids. It also has excellent local and systemic tolerability. MPA is effective in the treatment of facial and scalp eczema and sunburn and has shown promising results in the treatment of psoriasis. Its rapid efficacy and lack of undesirable local and/or systemic side effects make MPA particularly suitable for use in children and infants. The wide range of formulations (0.1%) of MPA, including cream, ointment, fatty ointment, milk and solution, enable treatment to be tailored to the individual patient. In addition, MPA has the advantage of once-daily application compared with twice-daily treatment for other topical corticosteroids, thereby improving patient safety and promoting patient compliance but without compromising efficacy.Keywords
This publication has 22 references indexed in Scilit:
- Methylprednisolone AceponateClinical Immunotherapeutics, 1995
- Long-term treatment with 6?-methylprednisolone aceponateJournal of the European Academy of Dermatology and Venereology, 1994
- Clinical comparison of methylprednisolone aceponate and prednicarbate in chronic eczemaJournal of the European Academy of Dermatology and Venereology, 1994
- Preclinical evaluation of a new topical corticosteroid methylprednisolone aceponateJournal of the European Academy of Dermatology and Venereology, 1994
- Pharmacokinetics and ‘bioactivation’ of MPAJournal of the European Academy of Dermatology and Venereology, 1994
- Skin atrophogenic potential of methylprednisolone aceponate (MPA)Journal of the European Academy of Dermatology and Venereology, 1994
- The prevalence of childhood atopic eczema in a general populationJournal of the American Academy of Dermatology, 1994
- Systemic effects of topically applied methylprednisolone aceponate in healthy volunteersJournal of the American Academy of Dermatology, 1993
- Clinical experience with methylprednisolone aceponate (MPA) in eczemaJournal of Dermatological Treatment, 1992
- The dermatology out-patient service: a study of out-patient referrals in a Scottish populationBritish Journal of Dermatology, 1984